SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-024095
Filing Date
2020-04-09
Accepted
2020-04-09 21:53:21
Documents
2
Period of Report
2020-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1517
2 POA DOCUMENT poa.txt EX-24.3_909642 3042
  Complete submission text file 0001209191-20-024095.txt   6066
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Issuer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, SUITE 250 AUSTIN TX 78746
Business Address
Bruhn Suzanne Louise (Reporting) CIK: 0001517790 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36257 | Film No.: 20785884